Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 2,531,800 | 2,733,801 | 2,778,900 | 2,775,000 | 2,694,000 |
| Cost of Goods | 753,900 | 660,100 | 511,800 | 459,700 | 478,100 |
| Gross Profit | 1,777,900 | 2,073,701 | 2,267,100 | 2,315,300 | 2,215,900 |
| Operating Expenses | 1,168,100 | 1,486,700 | 1,473,900 | 1,830,300 | 1,242,100 |
| Operating Income | 610,700 | 587,100 | 794,000 | 485,700 | 973,900 |
| Other Income | -266,600 | -164,400 | -501,800 | 130,700 | -525,100 |
| Pre-tax Income | 344,100 | 422,700 | 292,200 | 616,400 | 448,800 |
| Income Tax | 125,600 | 443,300 | -25,900 | -409,100 | 44,200 |
| Net Income Continuous | 218,500 | -20,600 | 318,100 | 1,025,500 | 404,600 |
| Minority Interests | -85,300 | -388,800 | -11,100 | 577,000 | -5,600 |
| Net Income | $303,800 | $368,200 | $329,200 | $448,500 | $410,200 |
| EPS Basic Total Ops | 2.06 | 2.52 | 2.22 | 3.00 | 2.70 |
| EPS Basic Continuous Ops | 1.49 | -0.08 | 2.15 | 6.85 | 2.66 |
| EPS Diluted Total Ops | 2.06 | 2.50 | 2.22 | 2.99 | 2.69 |
| EPS Diluted Continuous Ops | 1.48 | -0.08 | 2.14 | 6.83 | 2.66 |
| EBITDA(a) | $753,800 | $721,801 | $970,600 | $1,144,500 | $1,120,800 |